Motterlini Roberto, Clark James E, Foresti Roberta, Sarathchandra Padmini, Mann Brian E, Green Colin J
Vascular Biology Unit, Department of Surgical Research, Northwick Park Institute for Medical Research, Harrow, Middlesex, UK.
Circ Res. 2002 Feb 8;90(2):E17-24. doi: 10.1161/hh0202.104530.
Carbon monoxide (CO) is generated in living organisms during the degradation of heme by the enzyme heme oxygenase, which exists in constitutive (HO-2 and HO-3) and inducible (HO-1) isoforms. Carbon monoxide gas is known to dilate blood vessels in a manner similar to nitric oxide and has been recently shown to possess antiinflammatory and antiapoptotic properties. We report that a series of transition metal carbonyls, termed here carbon monoxide-releasing molecules (CO-RMs), liberate CO to elicit direct biological activities. Specifically, spectrophotometric and NMR analysis revealed that dimanganese decacarbonyl and tricarbonyldichlororuthenium (II) dimer release CO in a concentration-dependent manner. Moreover, CO-RMs caused sustained vasodilation in precontracted rat aortic rings, attenuated coronary vasoconstriction in hearts ex vivo, and significantly reduced acute hypertension in vivo. These vascular effects were mimicked by induction of HO-1 after treatment of animals with hemin, which increases endogenously generated CO. Thus, we have identified a novel class of compounds that are useful as prototypes for studying the bioactivity of CO. In the long term, transition metal carbonyls could be utilized for the therapeutic delivery of CO to alleviate vascular- and immuno-related dysfunctions. The full text of this article is available at http://www.circresaha.org.
一氧化碳(CO)在生物体内由血红素加氧酶降解血红素的过程中产生,该酶存在组成型(HO - 2和HO - 3)和诱导型(HO - 1)同工型。已知一氧化碳气体以类似于一氧化氮的方式扩张血管,并且最近已显示其具有抗炎和抗凋亡特性。我们报告了一系列过渡金属羰基化合物,在此称为一氧化碳释放分子(CO - RMs),它们释放CO以引发直接的生物活性。具体而言,分光光度法和核磁共振分析表明,十羰基二锰和二氯二羰基钌(II)二聚体以浓度依赖的方式释放CO。此外,CO - RMs在预收缩的大鼠主动脉环中引起持续的血管舒张,在离体心脏中减轻冠状动脉收缩,并在体内显著降低急性高血压。用血红素处理动物后诱导HO - 1可模拟这些血管效应,血红素可增加内源性产生的CO。因此,我们鉴定出了一类新型化合物,它们可作为研究CO生物活性的原型。从长远来看,过渡金属羰基化合物可用于CO的治疗性递送,以减轻与血管和免疫相关的功能障碍。本文的全文可在http://www.circresaha.org获取。